Skip to Content Facebook Feature Image

MOVING FORWARD ON CLIMATE CHANGE: MALAYSIA'S COMMITMENT TO A JUST AND ACCELERATED TRANSITION TOWARDS A SUSTAINABLE FUTURE

Business

MOVING FORWARD ON CLIMATE CHANGE: MALAYSIA'S COMMITMENT TO A JUST AND ACCELERATED TRANSITION TOWARDS A SUSTAINABLE FUTURE
Business

Business

MOVING FORWARD ON CLIMATE CHANGE: MALAYSIA'S COMMITMENT TO A JUST AND ACCELERATED TRANSITION TOWARDS A SUSTAINABLE FUTURE

2024-11-12 22:35 Last Updated At:22:55

BAKU, Azerbaijan, Nov. 12, 2024 /PRNewswire/ -- Malaysia has firmly set itself on the path of climate action. We are determined to act, regardless of what is happening in the world, because that is the right thing to do for the future of our people and country.

Despite contributing only 0.8% of global greenhouse gas (GHG) emissions, Malaysia is not resting on its laurels. As a developing Southeast Asian economy, we are uniquely positioned to continuously recalibrate our economic trajectory and activities to make significant progress on climate change and set an example for both regional and global counterparts, while also learning from the best practices from around the world.

We have made great strides in recent years, from policymaking to implementation through collaborations with various partners, at both domestic and international levels. This has only spurred us to be more proactive in addressing our climate and green transition agenda, including by setting an ambitious GHG emissions reduction target and safeguarding Malaysia against the impacts of climate change.

As the tip of the spear in Malaysia's fight against climate change, the Ministry of Natural Resources and Environmental Sustainability (NRES) which I lead has recalibrated our government's targets. Malaysia has decided to strive for net-zero GHG emissions by 2050 — an ambitious leap that reflects our determination to act now. Moving beyond the incremental, we are catalysing the rapid transformation that is required in line with global shifts.

In terms of policy and economic support, Malaysia aims to reach 31% renewable energy capacity by 2025 and 40% by 2035. As part of our Nationally Determined Contribution (NDC) under the Paris Agreement, Malaysia reaffirms its goal to reduce economy-wide carbon intensity by 45% by 2030. Malaysia is also in the process to set another ambitious NDC target in 2025.

The government has introduced the Madani Economy framework, National Energy Transition Roadmap (NETR) and the National Industrial Master Plan (NIMP) to take a whole of government approach towards sustainability. NRES is moving forward with our Climate Change Bill and National Adaptation Plan (MyNAP) to support the efforts.

On the regional front, Malaysia is actively supporting the establishment of an interconnected ASEAN energy grid, which will facilitate a sustainable energy network across Southeast Asia. This integration will not only strengthen regional energy security but also strengthen ASEAN's linkages in the global push for sustainable energy generation and consumption. Alongside this, Malaysia is leading the way in advancing carbon credits through the ASEAN Carbon Market Framework and addressing the pressing challenges of transboundary haze occurrences.

It goes without saying that this transition cannot solely rest on the shoulders of developing nations like Malaysia. The developed world cannot continue to move the goalpost in paying the climate debt. It must play its part by providing the financial support, technology transfer, and capacity-building needed to ensure a just and equitable transition for all. The burden of industrialisation weighs heavily on developed nations, and it is their responsibility to pave the way for their developing counterparts, ensuring that emerging economies are empowered to progress on this shift for sustainability without being left behind.

Malaysia has been continuously engaging with global climate change collaborators, such as the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH and the United Nations Children's Fund (UNICEF), to strengthen our climate resilience efforts and align our national initiatives with global climate action frameworks. We are also working to incubate our future generations with a sustainable-first mindset. The National Adaptation Plan will outline strategies and measures to help the country adapt to the impacts of climate change. Malaysia received approval from the Green Climate Fund on 22 August 2024 to develop the NAP. In the first year, we will focus on developing the National, Sub-National, and Sectoral Adaptation Plans by organising stakeholder consultations at the national, state, and sectoral levels.

While we are grateful for the support we have received—more is needed. We would do more and be more ambitious if we had the resources to do so. Developing countries can do more to advance as well as protect their interests by being generous with climate finance rather than hawking weapons of war and destruction or imposing misguided policies against certain commodities that are really thinly-disguised trojan horses for protectionism and at the same time pursuing "waste colonialism" against the rest of the world.

With international attention on COP29, Malaysia is determined to showcase its commitment to sustainability. This is something we will also pursue as ASEAN Chair in 2025. By positioning itself as a prime investment hub for green projects, Malaysia is seizing this moment to create highly-skilled green job opportunities that will support a sustainable future for our beloved nation.

Looking ahead, NRES in collaboration with the Malaysian Government and various local stakeholders remain committed to moving forward our climate agenda. We are seeking to not only respond to climate change, but position Malaysia as a sustainability powerhouse, confident that it is a bridge to a more prosperous and equitable future for all. 

NIK NAZMI NIK AHMAD

MINISTER OF NATURAL RESOURCES

AND ENVIRONMENTAL SUSTAINABILITY OF MALAYSIA

12 NOVEMBER 2024

About the Malaysian Pavilion

Malaysia is proud to present our Malaysia Pavilion at COP29, built around the theme "Shift for Sustainability: Climate Action Now". This theme emphasises the urgency of addressing climate change with immediate, bold actions. Through a whole-of-nation approach, Malaysia is committed to collaborating with all sectors—government, businesses, and communities—to create a sustainable and resilient future for all.

Join us at the Malaysia Pavilion as we showcase our nation's innovative solutions for climate action, from green urban development to energy transitions, biodiversity preservation, and more.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

MOVING FORWARD ON CLIMATE CHANGE: MALAYSIA'S COMMITMENT TO A JUST AND ACCELERATED TRANSITION TOWARDS A SUSTAINABLE FUTURE

MOVING FORWARD ON CLIMATE CHANGE: MALAYSIA'S COMMITMENT TO A JUST AND ACCELERATED TRANSITION TOWARDS A SUSTAINABLE FUTURE

PISCATAWAY, N.J., Nov. 13, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this vital sector, GenScript is bringing together leading scientists, industry experts, investors, and regulatory authorities at the GenScript Biotech Global Forum. This series of conferences aims to address key industrial trends in cell therapy and gene therapy.

For more information, please visit the forum website.
Scan QR code or click the link to register: https://bit.ly/477v0pa
(Register using code GSOM to reserve your free pass.)
 

In this November 20, GenScript Biotech Global Forum will take place in London during the Jefferies London Healthcare Conference. This year's forum will explore the theme "Unlock the Full Potential of Cell and Gene Therapies." This event aims to foster collaboration among industry leaders while tackling the challenges and opportunities in the CGT landscape.

Highlights of the Agenda Include

Navigating Challenges: Insights into the Future of CGT and Multiple Cell Therapy Technologies in Development

In recent years, cell and gene therapy has become a key player in biopharmaceuticals, with a growing number of approvals annually. CAR-T therapies are the most advanced, while innovations have led to a wider range of cell therapies, including CAR-NK, CAR-M, and TIL, addressing various challenging diseases.

However, the diverse landscape of new therapies and technologies presents numerous challenges. The forum will feature keynote speeches from prominent figures in cell and gene therapy, including Dr. James M. Wilson, President and CEO of Gemma Biotherapeutics; Dr. Miguel Forte, President of the International Society for Cell & Gene Therapy (ISCT) and CEO of Kiji Therapeutics, and Tom Whitehead, co-founder of the Emily Whitehead Foundation will also give a speech to share the life-saving stories of CAR-T therapy.

In-Depth Discussion on Gene Therapy, mRNA Vaccines and the CMC Challenges in Developing and Manufacturing CGT Product

The development of gene therapy and mRNA vaccine technologies has been transformative, particularly during the COVID-19 pandemic, and holds immense promise for treating rare diseases and genetic disorders. As advancements in gene editing reshape clinical applications, emerging innovations in gene therapy and mRNA vaccines are poised to revolutionize medicine. However, the transition of these technologies from research and development to clinical application brings significant challenges. Throughout the development and production of cell and gene therapies, issues related to CMC are prevalent. The quality of raw materials and the stability of supply chains directly impact early development, while the complexity and consistency of manufacturing processes, from small-scale trials to large-scale commercialization, remain key obstacles. Further optimization is needed in process scaling and standardization, alongside the ongoing challenge of ensuring product quality and safety in compliance with stringent regulatory standards for successful market entry. The forum will explore these challenges, as well as emerging market trends and future opportunities for innovation, through in-depth panel discussions.

Exploring the Investment Potential of CGT: A Future Outlook

The cell and gene therapy (CGT) industry faces challenges in investment returns due to high development costs, regulatory hurdles, and manufacturing complexities. However, significant opportunities exist in gene editing and cell-based therapies, which offer promise for treating various diseases. Attracting funding requires understanding the potential impact of these therapies and their path to commercialization. This forum will feature a fireside chat with investment insights, helping attendees explore CGT's potential and how to secure long-term returns as therapies progress toward commercialization.

For more information, please visit the forum website.
Scan QR code or click the link to register: https://bit.ly/477v0pa
(Register using code GSOM to reserve your free pass.)
 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Recommended Articles